Biotech Meets Bitcoin: Apimeds and MindWave Merge with $100M Backing
Apimeds Pharmaceuticals merges with MindWave Innovations, combining pain management biotech with AI-driven Bitcoin treasury solutions, backed by $100 million funding.
NOTRELOAD AI
Nvidia Invests $2B in Synopsys to Transform Engineering with AI
Nvidia invests $2 billion in Synopsys to accelerate AI-powered design and engineering. Partnership aims to revolutionize product development across semiconductor, aerospace, automotive industries.
Mattress maker Somnigroup Proposes $1.63B All-Stock Deal to Acquire Leggett & Platt
Somnigroup International has offered to acquire Leggett & Platt in a $1.63B all-stock deal, representing a 17% premium. Leggett & Platt’s board is reviewing the unsolicited proposal.
Galecto Gains Momentum with New Drug Class and Strong Funding
Guggenheim initiates coverage on Galecto with a Buy rating and $32 target, citing strong potential for its newly acquired drug DMR-001 and solid funding through 2029.
FDA Fast-Tracks New Blood Cancer Treatment CLN-049 for AML
Cullinan Therapeutics (CGEM) receives FDA Fast Track designation for CLN-049, a novel therapy showing promising results in treating relapsed acute myeloid leukemia patients.
Barrick Explores IPO for North American Gold Assets
Barrick Mining Corporation announces plans to evaluate an IPO of its North American gold operations, including Nevada Gold Mines and Pueblo Viejo, while maintaining majority control.